comparemela.com
Home
Live Updates
Neuroplast receives second orphan medicinal product designation for Neuro-Cells, paving the way for application to both chronic and trauma-induced neurodegenerative diseases : comparemela.com
Neuroplast receives second orphan medicinal product designation for Neuro-Cells, paving the way for application to both chronic and trauma-induced neurodegenerative diseases
Fast-track status is granted for frontotemporal dementia, next to the existing designation for traumatic spinal cord injury An orphan medicinal product designation or orphan disease designation
Related Keywords
Geleen
,
Limburg
,
Netherlands
,
Amsterdam
,
Noord Holland
,
Dutch
,
Kostenloser Wertpapierhandel
,
Erik Wolters
,
Brightlands Agrifood Fund
,
Committee For Orphan Medicinal Products
,
European Union
,
Netherlands Enterprise Agency
,
European Medicines Agency
,
Dutch Ministry Of Economic Affairs
,
Frontotemporal Dementia
,
Traumatic Spinal Cord Injury
,
Traumatic Brain
,
Advanced Therapy Medicinal Product
,
Orphan Medicinal Products
,
Johannes De Munter
,
Lumana Invest
,
Brightlands Venture Partners
,
Netherlands Enterprise
,
Brightlands Chemelot Campus
,
Venture Partners
,
Chemelot Ventures
,
Dutch Ministry
,
Economic Affairs
,
Spring Lifesciences Communication
,
Neuroplast
,
Eceives
,
Second
,
Orphan
,
Medicinal
,
Product
,
Resignation
,
Euro
,
Cells
,
Caving
,
Application
,
Moth
,
Hronic
,
Trauma
,
Induced
,
Neurodegenerative
,
Diseases
,
comparemela.com © 2020. All Rights Reserved.